LLY
Lilly(Eli) & Company
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Eli Lilly and Company (Ticker: LLY), headquartered in Indianapolis, Indiana, is a leading global pharmaceutical entity distinguished for its cutting-edge advancements in healthcare. The company primarily concentrates on therapeutic areas including diabetes, oncology, and neurodegenerative diseases, ...
$1,160.11
-2.07% ($24.52)
Volume
3.40M
52W High
$1,292.65
52W Low
$725.31
Market Cap
$994.90B
What to Watch This Quarter
Based on historical dataConsensus EPS
$9.56
Whisper EPS
$10.46
9.4% above consensus
Last Quarter
$8.38
Current Streak
6 Beats
Avg Surprise (4Q)
+18.92%
Next Earnings Report
Reports in 27 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Aug 5, 2026
1-Day:
+1.89%
5-Day:
+5.31%
Q1 2026
Apr 30, 2026
1-Day:
+3.07%
5-Day:
+5.81%
Q4 2025
Feb 11, 2026
1-Day:
+2.27%
Q4 2025
Feb 4, 2026
1-Day:
-7.79%
5-Day:
-5.64%
Revenue & Financial Performance
Revenue Whisper
$22.70B
TWN Proprietary Estimate
Last Quarter Revenue
$22.97B
+47.7% YoY
Gross Margin
85.8%
Net Margin: 30.9%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $22.97B | +47.7% | 85.8% | 54.2% | $7.10B |
| Q1'26 | $19.80B | +55.5% | 81.9% | 49.4% | $7.40B |
| Q4'25 | $19.29B | +42.6% | 82.5% | 46.6% | $6.64B |
| Q3'25 | $17.60B | +53.9% | 82.9% | 47.7% | $5.58B |
| Q2'25 | $15.56B | +37.7% | 84.3% | 45.1% | $5.66B |
| Q1'25 | $12.73B | +45.2% | 82.5% | 41.7% | $2.76B |
| Q4'24 | $13.53B | +44.7% | 82.2% | 42.0% | $4.41B |
| Q3'24 | $11.44B | +20.4% | 81.0% | 38.8% | $970.3M |
Company Information
Symbol
LLY
Company
Lilly(Eli) & Company
Market Cap
$994.90B
Sector
HEALTHCARE
Next Earnings
Oct 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as LLY
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare LLY with competitors
Side-by-side earnings comparison